中东和非洲疣治疗市场预测至 2028 年 - COVID-19 影响和按类型划分的区域分析(寻常疣、生殖器疣、扁平疣等);治疗(物理破坏、免疫调节和化学破坏);最终用户(医院、家庭护理、专科诊所等)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 137    |    Report Code: TIPRE00025055    |    Category: Life Sciences

Middle East and Africa Warts Therapeutics Market

市场介绍

疣是由人乳头瘤病毒(HPV)引起的皮肤生长。 HPV 有 60 多种类型,其中一些容易引起皮肤疣。局部治疗可能会在几周内解决疣问题,并且副作用最小。局部治疗可能并不总是有效。因此,液氮冷冻疗法是一种合适的治疗选择,其治愈率为60%至90%,复发率低于20%至10%。

因此,新产品的开发预计将创造未来几年对疣治疗药物的巨大需求,预计将进一步推动疣治疗市场的发展。

自 2020 年初以来,COVID-19 大流行已造成巨大的健康、社会和经济影响,这种情况可能会在 2021 年持续下去。即使其中一些影响得到减轻或遏制,仍将产生中长期后果。这一流行病对全世界的卫生服务造成了干扰,并影响了各国处理和应对性传播感染的能力。此外,经济的不确定性和持续的冲突正在使该地区的状况恶化。例如,叙利亚、利比亚、也门等国正遭受暴力冲突,无法落实任何公共卫生措施;伊朗则因美国制裁而陷入严重经济衰退。在许多国家,科技创新服务已被中断,关键商品的供应链已经捉襟见肘。在非洲,COVID-19 威胁到了艾滋病毒和其他性传播感染等主要高负担疾病的控制。随着 COVID-19 继续在非洲传播,人们担心其对妇女和女童的影响、有限的检测以及获得性传播感染专家临床的机会减少,进一步助长了由健康差异驱动的性传播感染流行,特别是在边缘化人群中。

 

市场概况与动态

中东和非洲的疣治疗市场预计将从 2021 年的 8160 万美元增长到 2028 年的 9660 万美元;预计2021年至2028年复合年增长率为2.4%。疣患病率的上升正在鼓励生命科学行业的公司专注于疣治疗新药的研发。为了获得更好的治疗效果,人们不断需要新的、创新的治疗方法。尽管很常见,但许多局部治疗需要多次给药,并且可能对复发无效。为了克服这一挑战,Cassiopea 正在开发 CB-06-02,一种 NCE 免疫调节剂,用于治疗尖锐湿疣。这是一种支持针对 HPV 的自然免疫反应的低毒性免疫调节剂,目前正处于 II 期临床试验中。根据迄今为止的药物分析,CB-06-02 预计将比现有疗法表现出更快的作用和更低的复发率。因此,不断增长的疣治疗药物管道是推动市场增长的主要力量。

 

关键细分市场

从类型来看,寻常疣细分市场在2020年中东和非洲疣治疗市场中占据最大份额。从治疗方式来看,物理破坏细分市场在中东和非洲疣治疗市场中占据最大份额2020年东非疣治疗市场。就最终用户而言,医院细分市场在2020年中东和非洲疣治疗市场中占据最大份额。

 

主要来源和上市公司

提到的一些主要一手和二手来源用于准备这份关于中东和非洲疣治疗市场的报告的有公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司包括 Bausch Health Companies Inc.、Euro Vital Pharma GmbH、Cipla Inc.、Koninklijke Utermöhlen NV、Scholl\'s Wellness Company、Teva Pharmaceutical Industries Ltd 和 GlaxoSmithKline plc。

 

购买理由报告

  • 了解中东和非洲疣治疗市场格局,并确定最有可能保证强劲的细分市场返回
  • 了解中东和非洲疣治疗市场不断变化的竞争格局,保持领先地位
  • 有效规划中东和非洲疣治疗市场的并购和合作交易通过识别最有前景的可能销售的细分市场来了解治疗市场
  • 通过对中东和非洲疣治疗市场各个细分市场的市场表现进行敏锐和全面的分析,帮助做出明智的业务决策
  • 获取中东和非洲地区2021-2028年各细分市场的市场收入预测

 

中东和非洲疣治疗市场细分

 

按类型

< ul>
  • 寻常疣
  • 生殖器疣
  • 扁平疣
  • 其他
  •  

    按治疗方式

    • 物理破坏
    • 冷冻疗法
    • 手术切除
    • 激光治疗
    • 免疫调节
    • < span>干扰素
    • 类维生素A
    • 化学破坏
    • 博来霉素
    • 斑蝥素
    • 水杨酸
    • 其他

     

    最终用户

    • 医院
    • 家庭护理
    • 专科诊所
    • 其他

     

    < span>按国家/地区

    • 中东和非洲
      • 阿联酋
      • 沙特阿拉伯
      • < li>南非
      • 中东和非洲其他地区

     

    < p>

    提及的公司

    1. Bausch Health Companies Inc.            
    2. Euro Vital Pharma GmbH               
    3. 西普拉公司               
    4. Koninklijke Uterm&oml;hlen NV               
    5. Scholl\'s Wellness Company            
    6. 梯瓦制药工业有限公司                
    7. 葛兰素史克公司。         

     

     

     

     

     

     

    Middle East and Africa Warts Therapeutics Strategic Insights

    Strategic insights for Middle East and Africa Warts Therapeutics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/middle-east-and-africa-warts-therapeutics-market-strategic-framework.webp
    Get more information on this report

    Middle East and Africa Warts Therapeutics Report Scope

    Report Attribute Details
    Market size in 2021 US$ 81.6 Million
    Market Size by 2028 US$ 96.6 Million
    Global CAGR (2021 - 2028) 2.4%
    Historical Data 2019-2020
    Forecast period 2022-2028
    Segments Covered By 类型
    • 普通疣
    • 生殖器疣
    • 扁平疣
    By 治疗
    • 物理破坏
    • 免疫调节
    • 化学破坏
    By 最终用户
    • 医院
    • 家庭护理
    • 专科诊所
    Regions and Countries Covered 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
    Market leaders and key company profiles
  • Bausch Health Companies Inc.
  • Euro Vital Pharma GmbH
  • Cipla Inc.
  • Koninklijke Utermöhlen NV
  • Schols Wellness Company
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc.
  • Get more information on this report

    Middle East and Africa Warts Therapeutics Regional Insights

    The regional scope of Middle East and Africa Warts Therapeutics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-warts-therapeutics-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East and Africa Warts Therapeutics Market

    1. Bausch Health Companies Inc.       
    2. Euro Vital Pharma GmbH                 
    3. Cipla Inc.                 
    4. Koninklijke Utermöhlen NV             
    5. Scholl's Wellness Company             
    6. Teva Pharmaceutical Industries Ltd             
    7. GlaxoSmithKline plc.      

                   

     

    Frequently Asked Questions
    How big is the Middle East and Africa Warts Therapeutics Market?

    The Middle East and Africa Warts Therapeutics Market is valued at US$ 81.6 Million in 2021, it is projected to reach US$ 96.6 Million by 2028.

    What is the CAGR for Middle East and Africa Warts Therapeutics Market by (2021 - 2028)?

    As per our report Middle East and Africa Warts Therapeutics Market, the market size is valued at US$ 81.6 Million in 2021, projecting it to reach US$ 96.6 Million by 2028. This translates to a CAGR of approximately 2.4% during the forecast period.

    What segments are covered in this report?

    The Middle East and Africa Warts Therapeutics Market report typically cover these key segments-

  • 类型 (普通疣, 生殖器疣, 扁平疣)
  • 治疗 (物理破坏, 免疫调节, 化学破坏)
  • 最终用户 (医院, 家庭护理, 专科诊所)
  • What is the historic period, base year, and forecast period taken for Middle East and Africa Warts Therapeutics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Warts Therapeutics Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Middle East and Africa Warts Therapeutics Market?

    The Middle East and Africa Warts Therapeutics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Bausch Health Companies Inc.
  • Euro Vital Pharma GmbH
  • Cipla Inc.
  • Koninklijke Utermöhlen NV
  • Schols Wellness Company
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc.
  • Who should buy this report?

    The Middle East and Africa Warts Therapeutics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East and Africa Warts Therapeutics Market value chain can benefit from the information contained in a comprehensive market report.